David Feifel

David Feifel

Department of Psychiatry, University of California, San Diego

Affiliated withUniversity of California, San Diego

Research Area

Biography

David Feifel has not added Biography.
If you are David Feifel and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1
Year
Treating Clinical Depression with Repetitive Deep Transcranial Magnetic Stimulation Using the Brainsway H1-coil
Publication title

Cited by 3

2016

Other Publications

Article
Year
Safety and tolerability of a rapidly escalating dose-loading regimen for risperidone.

The Journal of clinical psychiatry| PubMed ID: 11874225

2002
2002
2002
A systemically administered neurotensin agonist blocks disruption of prepulse inhibition produced by a serotonin-2A agonist.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology| PubMed ID: 12655309

2003
2003
2004
2004
2004
2004
2004
2005
2006
2006
2007
2007
2007
Dosing of divalproex extended release.

The Journal of clinical psychiatry| PubMed ID: 17685756

2007
2008
The neurotensin-1 receptor agonist PD149163 blocks fear-potentiated startle.

Pharmacology, biochemistry, and behavior| PubMed ID: 18577396

2008
Prepulse inhibition of startle in adults with ADHD.

Journal of psychiatric research| PubMed ID: 18674783

2009
Commentary: why diagnose and treat ADHD in adults?

Postgraduate medicine| PubMed ID: 18824821

2008
2008
2009
2010
2009
2008
2008
Treatment of autistic children.

Psychiatry (Edgmont (Pa. : Township))| PubMed ID: 19727292

2008
More depressing news on antidepressants: should we panic?

Psychiatry (Edgmont (Pa. : Township))| PubMed ID: 19727307

2008
2009
2009
2010
Daytrana: the first year.

Psychiatry (Edgmont (Pa. : Township))| PubMed ID: 20428306

2007
ADHD in adults: the invisible rhinoceros.

Psychiatry (Edgmont (Pa. : Township))| PubMed ID: 20436766

2007
An atomoxetine tutorial.

Psychiatry (Edgmont (Pa. : Township))| PubMed ID: 20532025

2007
2012
Promise and pitfalls of animal models of schizophrenia.

Current psychiatry reports| PubMed ID: 20544314

2010
2010
2010
Strattera: ups, downs, and emerging uses.

Psychiatry (Edgmont (Pa. : Township))| PubMed ID: 20711324

2007
Time to feel good: the therapeutic time course of antidepressants.

Psychiatry (Edgmont (Pa. : Township))| PubMed ID: 20805906

2007
When common clinical practice meets evidence-based medicine.

Psychiatry (Edgmont (Pa. : Township))| PubMed ID: 20877554

2006
Recent changes in prescriptions for antipsychotics in children and adolescents.

Psychiatry (Edgmont (Pa. : Township))| PubMed ID: 20975824

2006
2011
2011
Is oxytocin a promising treatment for schizophrenia?

Expert review of neurotherapeutics| PubMed ID: 21306203

2011
2011
2011
2012
2012
The effects of oxytocin and its analog, carbetocin, on genetic deficits in sensorimotor gating.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology| PubMed ID: 21962914

2012
Oxytocin as a potential therapeutic target for schizophrenia and other neuropsychiatric conditions.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology| PubMed ID: 22157870

2012
Dramatic improvement in sexual function induced by intranasal oxytocin.

The journal of sexual medicine| PubMed ID: 22458365

2012
2012
2012
2014
2012
2012
2013
2013
In reply:.

The western journal of emergency medicine| PubMed ID: 23875056

2012
2013
2013
2013
2013
2013
Oxytocin's role in anxiety: a critical appraisal.

Brain research| PubMed ID: 24468203

2014
2014
2015
2015
2016
Oxytocin modulates meta-mood as a function of age and sex.

Frontiers in aging neuroscience| PubMed ID: 26441637

2015
Effects of intranasal oxytocin on neural processing within a socially relevant neural circuit.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology| PubMed ID: 26727038

2016
2016
2016
2016